Unknown

Dataset Information

Monitoring islet specific immune responses in type 1 diabetes clinical immunotherapy trials.


ABSTRACT: The number of immunotherapeutic clinical trials in type 1 diabetes currently being conducted is expanding, and thus there is a need for robust immune-monitoring assays which are capable of detecting and characterizing islet specific immune responses in peripheral blood. Islet- specific T cells can serve as biomarkers and as such can guide drug selection, dosing regimens and immunological efficacy. Furthermore, these biomarkers can be utilized in patient stratification which can then benchmark suitability for participation in future clinical trials. This review focusses on the commonly used immune-monitoring techniques including multimer and antigen induced marker assays and the potential to combine these with single cell transcriptional profiling which may provide a greater understanding o

SUBMITTER: Arif S 

PROVIDER: S-EPMC10240960 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature